Evidence map›Paper›PMID 41370618›Full record

ArticleRevista brasileira de enfermagem2025

Side effects of hormone therapy in patients with malignant breast neoplasm: a cross-sectional study.

Erilaine de Freitas Corpes, Romel Jonathan Velasco Yanez, Cristina Poliana Rolim Saraiva Dos Santos, Monalisa Dutra Barbosa, Mayara Maria Silva da Cruz Alencar, Paulo César de Almeida, Ana Fátima Carvalho Fernandes, Régia Christina Moura Barbosa Castro

Abstract read
In one paragraph

Article in Revista brasileira de enfermagem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erilaine de Freitas CorpesUniversidade Federal do Ceará. Fortaleza, Ceará, Brazil.ORCID 0000-0002-9681-3422
Romel Jonathan Velasco YanezUniversidade Federal do Ceará. Fortaleza, Ceará, Brazil.ORCID 0000-0002-6969-8318
Cristina Poliana Rolim Saraiva Dos SantosUniversidade Federal do Ceará. Fortaleza, Ceará, Brazil.ORCID 0000-0001-9643-0264
Monalisa Dutra BarbosaUniversidade Federal do Ceará. Fortaleza, Ceará, Brazil.ORCID 0009-0000-3226-2775
Mayara Maria Silva da Cruz AlencarUniversidade Federal do Ceará. Fortaleza, Ceará, Brazil.ORCID 0000-0003-3064-7940
Paulo César de AlmeidaUniversidade Estadual do Ceará. Fortaleza, Ceará, Brazil.ORCID 0000-0002-2867-802X
Ana Fátima Carvalho FernandesUniversidade Federal do Ceará. Fortaleza, Ceará, Brazil.ORCID 0000-0001-5110-6364
Régia Christina Moura Barbosa CastroUniversidade Federal do Ceará. Fortaleza, Ceará, Brazil.ORCID 0000-0002-0673-9442

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesto evaluate the side effects of hormone therapy in patients with malignant breast neoplasia.

methodsa cross-sectional, analytical study conducted in a mastology outpatient clinic in Ceará, Brazil. Seventy-five women with breast cancer using tamoxifen or aromatase inhibitors were included and classified into four subgroups based on the type and duration of therapy. Fisher's exact test was used to assess the association between associated factors and the occurrence of side effects.

resultswomen using tamoxifen for >12 months had more sexual complaints. Hot flashes, musculoskeletal pain, and fatigue predominated in the anastrozole groups. There was a statistically significant association between side effects and daily lifestyle habits, previous treatment, and calcium replacement therapy.

conclusionsall groups presented some side effects and there are some factors that can intensify these symptoms, therefore, health professionals should monitor these effects to intervene early.

Indexed as

Antineoplastic Agents, HormonalBreast NeoplasmsAdultAgedAromatase InhibitorsBrazilCross-Sectional StudiesFemaleHumansMiddle AgedTamoxifenAntineoplastic Agents, HormonalAromatase InhibitorsTamoxifen

Identifiers

PMID41370618
PMCPMC12716806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.